Aurora Cancer Care-Kenosha South — Kenosha, Wisconsin

Aurora Cancer Care-Kenosha South is a clinical research site located in Kenosha, Wisconsin, United States 53142.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Aurora Cancer Care-Kenosha South has participated in 229 clinical trials with 152 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kenosha

Browse all research sites in Wisconsin · View every site in Kenosha

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aurora Cancer Care-Kenosha South?

Aurora Cancer Care-Kenosha South has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aurora Cancer Care-Kenosha South conducted?

Aurora Cancer Care-Kenosha South has 229 clinical trials on record, with 152 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Aurora Cancer Care-Kenosha South accredited by Crixeo Clinical Trials?

Aurora Cancer Care-Kenosha South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aurora Cancer Care-Kenosha South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.